Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Reports Second Quarter 2022 Financial Results

Business Wire May 5, 2022

Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022

Business Wire May 2, 2022

Twist Bioscience Launches High Throughput Antibody Production Platform

Business Wire April 28, 2022

Twist Bioscience to Become Voting Member of Storage Networking Industry Association

Business Wire April 21, 2022

Twist Bioscience Announces Promotions and Changes to Executive Leadership Team

Business Wire April 21, 2022

Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022

Business Wire April 18, 2022

Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies

Business Wire April 7, 2022

DNA Data Storage Alliance Welcomes 50th Member

Business Wire April 5, 2022

Twist Bioscience and Ginkgo Bioworks Sign New Collaboration

Business Wire April 5, 2022

Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene's Stainless Steel Capsules

Business Wire March 21, 2022

Abveris Named as One of the Best Places to Work

Business Wire March 10, 2022

Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy

Business Wire March 9, 2022

Twist Bioscience Becomes Digital Preservation Coalition Supporter

Business Wire February 28, 2022

Twist Bioscience to Present at Upcoming Virtual Conferences

Business Wire February 28, 2022

Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire February 15, 2022

Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock

Business Wire February 10, 2022

Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

Business Wire February 10, 2022

Twist Bioscience Announces Proposed Public Offering of Common Stock

Business Wire February 9, 2022

C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection

Business Wire February 8, 2022

Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools

Business Wire February 7, 2022